Meridian Bioscience Inc (NASDAQ:VIVO)

16.45
Delayed Data
As of Jun 15
 +0.35 / +2.17%
Today’s Change
13.35
Today|||52-Week Range
16.45
+17.50%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 15.50, with a high estimate of 17.00 and a low estimate of 11.00. The median estimate represents a -5.78% decrease from the last price of 16.45.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.18
Sales
$52.1M
Reporting Date
Jul 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -15.08%
 
 
 
 
 
 
Growthannually 5.47%
 
 
 
 
 
 

Sales

Growthquarterly -7.75%
 
 
 
 
 
 
Growthannually 5.69%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.